Takeda’s CMV Infection ‘Game-Changer’ Among EU Fast-Track Hopefuls
Calliditas Also Wants Accelerated Assessment For Novel Budesonide Drug
Takeda, Calliditas and Bayer are set to learn whether the European Medicines Agency will grant their respective products accelerated assessment status when they file for pan-EU marketing approval.
